Fluorescence Imaging PhD: Peptide Probes for Detecting Bacterial Infection

Fluorescence Imaging PhD: Peptide Probes for Detecting Bacterial Infection

Applicant assessment

This topic combines peptide-probe design, fluorescence imaging and infection research. It may suit applicants with experience in medicinal or pharmaceutical chemistry, chemical biology, microbiology, infection research or imaging who are comfortable working across disciplines. The central challenge is not simply generating fluorescence: the work must assess whether a probe can distinguish bacterial signal from mammalian-cell and sterile-inflammation backgrounds and produce interpretable results in relevant infection models. Rapid diagnosis and point-of-care use are translational aims, not established clinical outcomes.

Two saved fixed dates conflict: the GEMS rules list 25 January 2027, while the project record lists 31 January 2027. The materials do not show which date applies to this topic. Confirm with Monash; do not treat the later date as confirmed. This report uses saved project and scholarship materials and does not verify whether the vacancy is currently open.

Research question and doctoral work

The project responds to the difficulty of assessing topical and wound-associated infections, where bacterial adhesion and biofilm formation can complicate diagnosis and treatment decisions. It proposes fluorescently labelled peptide probes and optimisation of fluorophore–linker–peptide designs to improve bacterial-membrane interaction, wash-free labelling and selectivity against mammalian-cell or sterile-inflammation backgrounds. The researcher will compare performance across Gram-positive and Gram-negative bacteria and use imaging to quantify uptake, localisation and association with biofilms. The project description refers to relevant infection models but does not specify the model, sample type or whether animal work is involved.

The scientific value lies in linking probe design to infection-detection needs. Useful evidence would need to show not only a signal but also how reliably it can be interpreted against relevant backgrounds. Rapid diagnosis, image-guided sampling and point-of-care management are possible longer-term applications in the project description, not demonstrated clinical performance.

Papers and supervisory fit

The named supervisors have complementary areas. Dr Thet Thet Htar's public work includes medicinal chemistry and molecular imaging; Dr Polly Yap's includes medical microbiology, infectious-disease genomics and antimicrobial resistance; Dr Amandeep Kaur works on fluorescent probes, sensors and biological imaging; Prof. Cornelia Landersdorfer works on antimicrobial pharmacology, biofilms and modelling. This provides a cross-disciplinary basis for the topic. The saved materials do not specify day-to-day supervision across the two countries, and adjacent expertise does not guarantee that each published capability will be used directly in this project.

The saved papers support related expertise rather than completed work on this PhD:

• Kaur's 2026 fluorogenic rhodamine-probe paper concerns wash-free, high-resolution cell-membrane imaging. It signals probe and imaging experience, but the application is not bacterial infection imaging. Publication record
• A 2025 paper associated with Landersdorfer's team examines antimicrobial treatment and biofilms. It is relevant to the biofilm context, but not to fluorescent-probe design. Publication record
• Yap's 2024 antimicrobial-resistance surveillance paper reflects microbiology and genomics experience, rather than imaging chemistry. Publication record
• Htar's 2025 curcumin-analogue modelling paper illustrates medicinal-chemistry optimisation, but studies a different disease topic. Publication record

Two field papers are closer to the concept. A 2024 peptide-hybrid probe paper reports an infection-imaging application; it is a precedent for peptide probes in infection recognition, not evidence that this project uses the same design. PubMed paper A separate paper on wash-free peptide-based microbial imaging is more directly related to the project's wash-free imaging aim, but does not establish the project's eventual design or results. Wiley paper

School, field and training

The project is based in the School of Pharmacy at Monash University Malaysia in Sunway. The Pharmacy PhD page describes an independent research project supported by at least two supervisors. The advertised team spans Malaysia and Australia, but the day-to-day supervision split, primary work location and mobility plan need confirmation.

Saved university materials list analytical facilities in the School of Pharmacy and broader Monash platforms for microscopy, flow cytometry, omics and biomedical imaging. These support a plausible environment for probe and imaging work; they do not guarantee that this project has access, booked time or dedicated technical support. Monash's 2026 overall and pharmacy/pharmacology rankings provide context, not a substitute for evaluating project resources and supervision. The saved ranking sources are QS overall ranking announcement, QS pharmacy and pharmacology announcement and THE profile.

Funding, application and living costs

The saved GEMS rules list 42 months of funding and a 100% tuition waiver for up to 4 years. The Malaysia stipend is RM 2,950 per month. For mobility, the listed stipend is RM 8,500 per month for up to 9 months in Australia, or RM 2,950 per month in Indonesia or at IIT Bombay. A further RM 9,000 grant is listed for visa, insurance and travel-related costs. The mobility host for this topic and the coverage of research consumables or other expenses are not stated. The stipend and expense grant are separate items. GEMS scholarship rules

The rules include Malaysian and international applicants, require full-time study and academic and English eligibility, and set a minimum of First Class Honours (H1) or an H1-equivalent recognised by Monash Malaysia. The saved English-requirements page lists IELTS 6.5 overall with no band below 6.0 for Pharmacy and Pharmaceutical Sciences; confirm the accepted test version, validity and individual degree equivalence with the university. Graduate-research English requirements

The project text says applicants select the scholarship type within their degree application and do not submit a separate scholarship application. It recommends contacting the main supervisor first. Listed application materials include transcripts and certificates, a CV, a 300-word personal statement, a proposal for the selected topic, English evidence and any publications. International applicants also need a student pass; confirm the applicable process and timing with the university. Student-pass information

Monash Malaysia's cost guide gives examples including university accommodation at RM 330–1,500 per month. Those are examples rather than a personal housing offer or complete budget. Applicants should account separately for housing, insurance, visas, travel and any research costs not covered by the award. Cost-of-living guide

Applicant preparation and questions

Relevant backgrounds include medicinal or pharmaceutical chemistry, peptide chemistry, chemical biology, microbiology, infection research, fluorescence imaging and quantitative analysis. Applications can show fit through one or two examples of independent research, interpreting data or working across disciplines; the project materials do not require prior specialist experience beyond the stated scholarship and admission conditions.

Before applying or at interview, ask:

• Which date, 25 or 31 January 2027, applies to this topic, and when will the application portal stop accepting submissions?
• Which infection models and sample types are planned, and what ethical approvals or animal or clinical materials may be involved?
• How are the four supervisors' day-to-day roles divided, where will the work take place, and what mobility is expected?
• Which imaging facilities and technical support are actually available to this project?
• Which research, travel and other expenses are covered, and what are the award continuation conditions?
• How will the university assess the applicant's degree equivalence, English evidence and student-pass timeline?

The training could lead toward academic or industry work in chemical biology, infection imaging, pharmacy or diagnostics research. Those paths depend on the skills and results developed during the PhD; the project title does not guarantee a particular outcome. The saved public-health context includes WHO's AMR overview, the GLASS 2025 summary and Malaysia's AMR action plan: WHO AMR overview, WHO GLASS 2025 and Malaysia MyAP-AMR.

Sources

Project and training: GEMS 2027 project, Pharmacy PhD, School of Pharmacy.

Supervisors and facilities: Thet Thet Htar, Polly Yap, Amandeep Kaur, Kaur Group, Cornelia Landersdorfer, related antimicrobial-pharmacology PhD project, Pharmacy research facilities, Monash Research Platforms.

Research and institutional context: WHO AMR overview, WHO GLASS 2025, Malaysia MyAP-AMR, 2024 peptide-hybrid infection-imaging paper, wash-free microbial imaging paper.

Funding and application: GEMS rules, graduate-research English requirements, student pass, cost of living, QS overall ranking announcement, QS pharmacy and pharmacology announcement, THE Monash profile.